Hudson Bay Capital Management
APLT

Hudson Bay Capital Management’s Applied Therapeutics APLT Stock Holding History

Hudson Bay Capital Management’s Portfolio APLT Stock Details APLT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-673,764
Closed -$408K – 1186
2025
Q3 		$408K Buy
+673,764
New +$317K ﹤0.01% 935

Other funds holding APLT

T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
KCM
Knoll Capital Management Miami, Florida $180M AUM 66.11% 1-Year Est. Return
DAM
Deltec Asset Management New York $677M AUM 31.67% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Pathstone Holdings
Pathstone Holdings Englewood, New Jersey $25.1B AUM 22.95% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Jane Street
Jane Street New York $777B AUM 61.18% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return

Hudson Bay Capital Management's APLT Position: Q4 2025 in Review

Hudson Bay Capital Management sold out of Applied Therapeutics (APLT) in Q4 2025, closing a stake of 673,764 shares — an estimated $408K sold.

Hudson Bay Capital Management first reported a position in APLT in Q3 2025 and held it in 1 quarter. The position peaked at $408K in Q3 2025. 52 funds tracked by Wall St. Rank hold APLT as of Q4 2025.

  • Hudson Bay Capital Management reported no remaining Applied Therapeutics position as of Q4 2025 after selling out during the quarter.
  • Hudson Bay Capital Management sold 673,764 Applied Therapeutics shares in Q4 2025, an estimated $408K.
  • Hudson Bay Capital Management first reported a position in Applied Therapeutics in Q3 2025 and held it in 1 quarter.
  • Hudson Bay Capital Management's Applied Therapeutics position peaked at $408K in Q3 2025.
  • 52 funds tracked by Wall St. Rank held Applied Therapeutics as of Q4 2025.

Based on Hudson Bay Capital Management's 13F filing for Q4 2025, filed 13 Feb 2026.